The use of modern GLP1 injectables, such as Ozempic, is widespread - almost everyone knows someone who has taken these drugs for weight loss. Patients report thinking less about food, fewer cravings, feeling more ‘normal’ and weight loss. This workshop will introduce you to commonsense science explanations for these effects from a medical and personal experience (Gabriele).
Complementing this, mindfulness techniques for increasing awareness of your bodies’ own signals will help
align daily habits with your own metabolism (Pam). Demystifying GLP1s and increasing mindfulness can
help meet your own, and support other’s, weight management goals.
Attendees will be able to have their questions answered and concerns discussed in a safe, compassionate environment.
This workshop is offered in person in our Wellness Center, Suite 1C, 2 Village Road, Horsham.
Or, you may choose to attend virtually, and a link will be sent to you to join the workshop from your remote location.
WEDNESDAY MAY 13 Noon - 1 pm
Investment = $35
Monthly Unlimited Autopay Members $28
Students and 60+ $28
BIOS -Pam Hornby, PhD, is an accomplished scientist of gut and digestive health who received her PhD at the University of Kentucky, then trained in Pharmacology at Georgetown University Medical School. She taught in the Department of Pharmacology at Louisiana State University Medical School, New Orleans, for twelve years before joining Drug Discovery at Janssen Pharmaceutical R&D in Pennsylvania. Pam is now also a certified Ayurvedic Counselor and founder of Giv Gastrointestinal Vitality LLC.
Gabriele Ronnett, MD, PhD, is a medical specialist in many areas, and has served as the Gestational Diabetes (GDM) Venture Leader in the Disease Interception Accelerator (DIA) at Janssen Research & Development within Johnson & Johnson. She was Professor of Neuroscience, Neurology, and Biological Chemistry at Johns Hopkins University School of Medicine, where she was also the Founding Director of the Center for Metabolism and Obesity Research (CMOR) and one of the Founding Directors of the Center for Integrated Resources in Biology at Johns Hopkins.
Gabriele Ronnett, MD, PhD, is a medical specialist in many areas, and has served as the Gestational Diabetes (GDM) Venture Leader in the Disease Interception Accelerator (DIA) at Janssen Research & Development within Johnson & Johnson. She was Professor of Neuroscience, Neurology, and Biological Chemistry at Johns Hopkins University School of Medicine, where she was also the Founding Director of the Center for Metabolism and Obesity Research (CMOR) and one of the Founding Directors of the Center for Integrated Resources in Biology at Johns Hopkins.